Abbott Laboratories (ABT)

51.62
0.21 0.40
NYSE : Health Care
Prev Close 51.41
Open 51.39
Day Low/High 51.39 / 51.83
52 Wk Low/High 37.38 / 52.60
Volume 3.26M
Avg Volume 5.07M
Exchange NYSE
Shares Outstanding 1.74B
Market Cap 90.49B
EPS 0.90
P/E Ratio 81.38
Div & Yield 1.06 (2.00%)

Latest News

Fight Off Complacency: Cramer's 'Mad Money' Recap (Fri 9/15/17)

Fight Off Complacency: Cramer's 'Mad Money' Recap (Fri 9/15/17)

Jim Cramer says the market may be shaking off bad news and threats, but recent positivity is unusual. Don't speculate, be diversified and don't feel bad about taking profits.

Alibaba, Qorvo, Abbott Laboratories, Square: 'Mad Money' Lightning Round

Alibaba, Qorvo, Abbott Laboratories, Square: 'Mad Money' Lightning Round

Jim Cramer is bullish on Alibaba, Qorvo, Abbott Laboratories, Square, and Baozun.

Weekly Roundup

Hurricane Irma damage is less than expected, which lifts markets. In the portfolio, we add to one position while updating the ratings on two others.

FreeStyle® Libre Flash Glucose Monitoring Technology Gains Reimbursement Approval From The United Kingdom's National Health Service

FreeStyle® Libre Flash Glucose Monitoring Technology Gains Reimbursement Approval From The United Kingdom's National Health Service

- REVOLUTIONARY FREESTYLE® LIBRE SYSTEM ALLOWS PEOPLE WITH DIABETES TO CHECK THEIR GLUCOSE WITHOUT CALIBRATION OR ROUTINE FINGER STICKS[i]

Weekly Roundup

Markets keep an eye on the storms while the Fed has a surprise. We add a name to the portfolio.

Abbott Named Industry Leader For Responsible And Sustainable Business For Five Consecutive Years On The Dow Jones Sustainability Index (DJSI)

Abbott Named Industry Leader For Responsible And Sustainable Business For Five Consecutive Years On The Dow Jones Sustainability Index (DJSI)

- Abbott is the only U.S.-based company among 24 global industry leaders

Walmart Is One of 63 Companies Contributing Massively to Aid Harvey Relief

Walmart Is One of 63 Companies Contributing Massively to Aid Harvey Relief

Corporations have contributed at least $141.3 million to aid Hurricane Harvey relief efforts, as of Friday.

Weekly Roundup

Markets advance despite Hurricane Harvey, North Korea impacts.

Bristol-Myers Squibb, Pfizer, Abbott Are on the Move: Buy These Target Prices

Bristol-Myers Squibb, Pfizer, Abbott Are on the Move: Buy These Target Prices

Check out these three big movers today.

Revolutionary Glucose Monitoring Technology FreeStyle® Libre Now Reimbursed Across Japan

Revolutionary Glucose Monitoring Technology FreeStyle® Libre Now Reimbursed Across Japan

- NATIONALLY REIMBURSED FOR ALL PEOPLE WITH DIABETES ON INSULIN THERAPY - MORE THAN 1 MILLION PEOPLE, BOTH TYPE 1 AND TYPE 2

Abbott Initiates Ground-breaking U.S. Pivotal Study Of AMPLATZER Device To Correct Common Congenital Heart Defect In Newborns

Abbott Initiates Ground-breaking U.S. Pivotal Study Of AMPLATZER Device To Correct Common Congenital Heart Defect In Newborns

- 80,000 PRE-TERM BABIES IN THE U.S. ARE BORN WITH A LIFE-THREATENING OPENING IN THEIR HEART EACH YEAR, AND 16,000 OF THEM NEED URGENT TREATMENT TO SURVIVE

Abbott Updates Pacemaker, Defibrillator Software to Protect Against Hacking

Abbott Updates Pacemaker, Defibrillator Software to Protect Against Hacking

Abbott Laboratories has rolled out a number of new software updates for its healthcare devices, intended to boost their safety.

Abbott And The Abbott Fund Donate $1 Million To Support Hurricane Harvey Relief Efforts

Abbott And The Abbott Fund Donate $1 Million To Support Hurricane Harvey Relief Efforts

DONATION BUILDS ON EARLIER WORK WITH NON-PROFIT PARTNERS TO PREPARE FOR HURRICANE SEASON, HELPING AFFECTED COMMUNITIES TO QUICKLY RESPOND TO MEET LOCAL NEEDS

FDA Approves Abbott Heart Device, Stock Rises

FDA Approves Abbott Heart Device, Stock Rises

The HeartMate 3 received regulatory approval.

Assessing the Markets and Portfolio Amid Hurricane Harvey

Updates on Abbott, energy stocks, Southwest and Broadcom.

Abbott Introduces HeartMate 3 Left Ventricular Assist System - The Latest Milestone In Therapy For Advanced Heart Failure Patients

Abbott Introduces HeartMate 3 Left Ventricular Assist System - The Latest Milestone In Therapy For Advanced Heart Failure Patients

- Abbott pioneered the evolution of heart pumps; U.S. approval of the HeartMate 3™ system further broadens its market-leading heart failure portfolio

How EY's Kerrie MacPherson Uses Decades of Experience to Help a New Generation of Women Win

How EY's Kerrie MacPherson Uses Decades of Experience to Help a New Generation of Women Win

EY's Kerrie MacPherson Wants To Pave the Way for future female entrepreneurs.

Weekly Roundup

Trump has both good news and bad news for the market, while Yellen has no news. In the portfolio, we add to 3 positions and upgrade another.

The New #161 Most Shorted S&P 500 Component: Abbott Laboratories

The most recent short interest data has been released for the 08/15/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Weekly Roundup

Political turmoil, terror attack and sharp pullback mark this week's action.

EY's Kerrie MacPherson:

EY's Kerrie MacPherson: "If You Can See It, You Can Be It"

EY's Kerrie MacPherson wants to remove the barriers for young women.

Weekly Roundup

Markets see volatility as geopolitical tensions rise. We closed out one tech position and initiated another.

Weekly Roundup

Strong earnings and guidance lift markets. We drop a couple of names from the portfolio.

Weekly Roundup

Earnings help boost markets as D.C. isn't counted on for much of anything. Portfolio action (it was a busy week) includes a new position and a downgrade.

Freeport-McMoRan, Apple Hospitality REIT, Abbott Laboratories: 'Mad Money' Lightning Round

Freeport-McMoRan, Apple Hospitality REIT, Abbott Laboratories: 'Mad Money' Lightning Round

Jim Cramer is bullish on Freeport-McMoRan, Apple Hospitality REIT, and Abbott Laboratories.

Reversal of Fortunes: Cramer's 'Mad Money' Recap (Thursday 7/27/17)

Reversal of Fortunes: Cramer's 'Mad Money' Recap (Thursday 7/27/17)

Jim Cramer says that when the markets switch abruptly, investors should take the opportunity to go bargain hunting.

TheStreet Quant Rating: B (Buy)